Envestnet Asset Management
MIRM icon

Envestnet Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Envestnet Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.08M Buy
22,563
+2,077
+10% +$195K ﹤0.01% 2985
2025
Q4 		$1.62M Buy
20,486
+13,684
+201% +$982K ﹤0.01% 2988
2025
Q3 		$499K Buy
6,802
+1,473
+28% +$93.6K ﹤0.01% 3765
2025
Q2 		$271K Buy
+5,329
New +$237K ﹤0.01% 4082

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Envestnet Asset Management's MIRM Position: Q1 2026 in Review

Envestnet Asset Management increased its Mirum Pharmaceuticals (MIRM) stake by 10% in Q1 2026, buying an estimated $195K and bringing the position to 22,563 shares worth $2.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2985.

Envestnet Asset Management first reported a position in MIRM in Q2 2025 and has held it in 4 quarters since. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Envestnet Asset Management held 22,563 shares of Mirum Pharmaceuticals worth $2.08M as of Q1 2026.
  • Envestnet Asset Management bought 2,077 Mirum Pharmaceuticals shares in Q1 2026, an estimated $195K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Envestnet Asset Management's portfolio in Q1 2026, its #2985 holding.
  • Envestnet Asset Management first reported a position in Mirum Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.